Document ID: chunk:federal_register_of_legislation:F2023L00054:reg:6
Version: federal_register_of_legislation:F2023L00054
Segment Type: reg
Provision Reference: reg 6
Character Range: 2579–3430

6  Form of information
  For the purposes of subparagraph 26BD(3)(e)(ii) of the Act, the information that must accompany an application for a recommendation by the Secretary that the Minister vary a section 26BB determination must be:
 (a) contained in an application dossier; and
 (b) in a form consistent with the document titled Mandatory requirements for an effective application to vary the Permissible Ingredients Determination (Version 1.0, February 2023), published by the Therapeutic Goods Administration, as in force or existing on 1 February 2023; and
 (c) in a form consistent with the document titled General dossier requirements (Version 1.4, July 2018) published by the Therapeutic Goods Administration, as in force or existing on 1 February 2023.
Note: The documents mentioned in paragraphs (b) and (c) are published at www.tga.gov.au.